Peri-Op RBC Transfusions Linked to Postoperative VTE
Perioperative red blood cell transfusion linked to increased adjusted odds of VTE, DVT, PE.
Perioperative red blood cell transfusion linked to increased adjusted odds of VTE, DVT, PE.
May be as effective as full-dose direct oral anticoagulants for extended-duration treatment.
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin.
Pharmacomechanical thrombolysis used with anticoagulation treatment, did not decrease post-thrombotic syndrome risks but increased major bleeding risks in patients with acute proximal DVT.
Fewer VTE events were observed in the betrixaban than enoxaparin arm.
VTE is more common among dialysis patients than in the general population, and the risk is highest in the first 6 months after dialysis initiation.
Venous thromboembolism is associated with a 4.1-fold increased risk of death and a 2.3-fold increased risk of death-censored graft loss among kidney transplant recipients.